What is the recommended treatment for enteric fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enteric Fever

First-Line Empiric Treatment

For uncomplicated enteric fever, azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days is the recommended first-line therapy, particularly in regions with high fluoroquinolone resistance. 1

  • Azithromycin demonstrates a 94% cure rate in children with typhoid fever and significantly lower relapse risk (OR 0.09) compared to ceftriaxone 1
  • This agent shows lower clinical failure rates (OR 0.48) and shorter hospital stays compared to fluoroquinolones in systematic reviews 1
  • Azithromycin is highly effective against extensively drug-resistant (XDR) Salmonella, with 98.1% effectiveness demonstrated in recent studies 2

Severe Cases Requiring Hospitalization

For patients requiring inpatient treatment or presenting with sepsis, ceftriaxone 50-80 mg/kg/day (maximum 2g/day) intravenously for 5-7 days is the preferred initial therapy. 1, 3

  • For adults, ceftriaxone 1-2g every 12-24 hours is appropriate based on severity 3
  • Blood cultures should be obtained before initiating antibiotics whenever possible 1, 3
  • Broad-spectrum antimicrobial therapy should be started immediately after blood culture collection in patients with clinical features of sepsis 1, 3

Alternative Oral Options

Cefixime 8 mg/kg/day as a single daily dose for 7-14 days can be used as an alternative oral option, though it may not perform as well as fluoroquinolones or azithromycin. 1, 4

  • For adults, cefixime 400 mg orally in a single dose is typically recommended 1
  • Clinical failure, microbiological failure, and relapse may be increased with cefixime compared to fluoroquinolones (RR 13.39,95% CI 3.24 to 55.39 for clinical failure) 4
  • Time to defervescence may be longer with cefixime compared to fluoroquinolones (mean difference 1.74 days) 4

Fluoroquinolone Use: Geographic Considerations

Fluoroquinolones (ciprofloxacin 500 mg twice daily for 7 days or ofloxacin) should only be used for fully susceptible S. typhi strains, and are NOT recommended for empiric therapy in South Asia due to widespread resistance. 1, 5, 6

  • Over 70% of S. typhi isolates in many regions are now resistant to fluoroquinolones 1, 3
  • Ciprofloxacin is FDA-approved for typhoid fever caused by Salmonella typhi 5
  • In populations with nalidixic acid resistance (NaR), fluoroquinolones show higher clinical failure rates compared to azithromycin (RR 2.20,95% CI 1.23 to 3.94) 6
  • Gatifloxacin may remain effective in some regions where resistance to older fluoroquinolones has developed 6

Treatment Duration and Transition to Oral Therapy

Most patients with uncomplicated enteric fever require 7 days of appropriate antibiotics, with transition to oral therapy once clinical improvement occurs and temperature has been normal for 24 hours. 1, 3

  • Expected fever clearance occurs within 4-5 days of appropriate therapy 1
  • Patients initially treated with parenteral antibiotics should be transferred to oral regimen as soon as clinically appropriate 1, 3

Special Populations

Infants under 3 months should be treated with a third-generation cephalosporin. 1

Critical Pitfalls to Avoid

  • Never use ciprofloxacin empirically for cases originating from South Asia due to resistance rates exceeding 70% 1, 3
  • Always obtain blood cultures before starting antibiotics when possible; also collect stool and urine cultures in suspected sepsis cases 1, 3
  • Do not rely solely on clinical presentation for diagnosis—microbiological confirmation is essential 1, 3
  • Modify therapy when susceptibility results become available rather than continuing empiric treatment 1, 3
  • Consider local resistance patterns when selecting empiric therapy, as these vary geographically and change over time 1, 3
  • Avoid premature discontinuation of antibiotics before complete resolution of symptoms 3

Monitoring and Complications

  • Reassess fluid and electrolyte balance in patients with persistent symptoms 1
  • For patients with persistent peritoneal irritation, failure of bowel function to normalize, or continued fever/leukocytosis, consider CT imaging to identify persistent or new intra-abdominal infection 3
  • Isotonic intravenous fluids are recommended for severe dehydration 3

References

Guideline

Treatment of Enteric Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Enteric Fever in Inpatient Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

Research

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).

The Cochrane database of systematic reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.